Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Vaccines Establishes New Vaccines CDMO Facility in China 2022-11-15 12:45
HARBOUR BIOMED LAUNCHES NONA BIOSCIENCES' "IDEAS TO IND" PRECLINICAL SOLUTIONS BUSINESS TO ACCELERATE GLOBAL BIOTHERAPEUTIC INNOVATION 2022-11-15 12:19
Biotheus has entered into a license and collaboration agreement with Hansoh Pharma for its EGFR/MET bispecific antibody in the Greater China territory 2022-11-15 11:16
VentureBlick Launches Global Search for Healthcare Startups 'Most Endorsed by the Medical Community' 2022-11-15 09:00
AIRS Medical showcases award-winning MRI enhancement AI solution at RSNA 2022 2022-11-14 23:00
Shiang Ding Targets US Market With Healthy Herbal Beverage Alternatives 2022-11-14 23:00
The World's First ETa-specific Monoclonal Antibody: Gmax Biopharm's GMA131 Approved by the US FDA for Clinical Study on (DKD) Diabetic Kidney Disease 2022-11-14 22:55
Meihua International Medical Technologies Co., Limited Reports Unaudited 2022 First Half Financial Results 2022-11-14 21:00
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China 2022-11-14 09:54
SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969 2022-11-14 08:00
Akeso's Ivonescimab (PD-1/VEGF Bispecific Antibody, AK112) Granted Breakthrough Therapy Designation for I-O Resistance NSCLC Patients in China 2022-11-14 08:00
INDUSTRY INNOVATION: AI SMILE Smart Tracking Case debut worldwide developed by Weiyun AI & Robotics Group 2022-11-11 21:35
So-Young to Report Third Quarter 2022 Financial Results on November 18, 2022 2022-11-11 18:11
CHOCOLATE TOUCH®, NEXT-GENERATION DRUG-COATED ANGIOPLASTY BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE RECEIVES FDA APPROVAL 2022-11-11 14:00
The new THREAD LIFT with approved design patent "TIMEMACHINE LIFT THREAD, ANCHORING DUAL COG" 2022-11-11 12:55
J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA 2022-11-11 10:30
Harbour BioMed Enters into a License and Collaboration Agreement with Moderna 2022-11-11 09:03
Antengene Presents Promising Results from Four Preclinical Studies at the 2022 Society for Immunotherapy of Cancer Annual Meeting 2022-11-11 08:30
Alma Academy was Successfully Held in Dubai with the Global Launch of Alma Duo 2022-11-10 23:57
ITRI Introduces Point-of-Care AI-DR Software for Rapid Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema 2022-11-10 22:00
1 129 130 131 132 133 812